# Liposomal Bupivacaine in Rotator Cuff Repair

> **NCT03738696** · PHASE4 · COMPLETED · sponsor: **University of Alabama at Birmingham** · enrollment: 64 (actual)

## Conditions studied

- Rotator Cuff Injury

## Interventions

- **DRUG:** Exparel
- **DRUG:** Ropivacaine

## Key facts

- **NCT ID:** NCT03738696
- **Lead sponsor:** University of Alabama at Birmingham
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-12-15
- **Primary completion:** 2022-01-01
- **Final completion:** 2022-01-01
- **Target enrollment:** 64 (ACTUAL)
- **Last updated:** 2024-05-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03738696

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03738696, "Liposomal Bupivacaine in Rotator Cuff Repair". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT03738696. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*